{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:31Z","timestamp":1787010391632,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":3787,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1097\/wox.0b013e3181af7c93","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T14:49:29Z","timestamp":1250174969000},"page":"166-179","source":"Crossref","is-referenced-by-count":14,"title":["The Treatment of Vasomotor Rhinitis With Intranasal Corticosteroids"],"prefix":"10.1016","volume":"2","author":[{"given":"Eli O.","family":"Meltzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/WOX.0b013e3181af7c93_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 76","key":"10.1097\/WOX.0b013e3181af7c93_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.0108-1675.2004.00388.x","article-title":"Mechanisms of vasomotor rhinitis","volume":"59","author":"Garay","year":"2004","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0091-6749(97)70267-7","article-title":"The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with non-allergic, non-infectious perennial rhinitis","volume":"100","author":"Blom","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0020","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1067\/mai.2001.115563","article-title":"Pharmacokinetics of intranasal steroids","volume":"108","author":"Szefler","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.1.5800.585","article-title":"Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma","volume":"1","author":"Morrow Brown","year":"1972","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0030","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","article-title":"Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications","volume":"63","author":"Derendorf","year":"2008","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJM199109193251206","article-title":"Allergic rhinitis","volume":"325","author":"Naclerio","year":"1991","journal-title":"New Engl J Med"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0040","first-page":"125","article-title":"The position not the presence of the halogen in corticosteroids influences potency and side effects","volume":"5","author":"Bikowski","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-199856040-00018","article-title":"Mometasone furoate. A review of its intranasal use in allergic rhinitis","volume":"56","author":"Onrust","year":"1998","journal-title":"Drugs"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0091-6749(98)70053-3","article-title":"Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray","volume":"102","author":"Meltzer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0055","first-page":"181","article-title":"The efficacy of a new medication - intranasal glucocorticoid mometasone furoate (Nasonex) - in seasonal allergic rhinitis","volume":"52","author":"Chyrek-Borowska","year":"1998","journal-title":"Otolaryngol Pol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0060","first-page":"648","article-title":"Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis","volume":"118","author":"Minshall","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0065","series-title":"Antiinflammatory Steroid Action: Basic and Clinical Aspects","first-page":"110","article-title":"Lymphocyte death induced by glucocorticoids","author":"Cohen","year":"1989"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0070","first-page":"192","article-title":"Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis","volume":"82","author":"Masuyama","year":"1994","journal-title":"Immunology"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0075","first-page":"193","article-title":"Fluticasone propionate aqueous nasal spray reduces nasal eosinophils and cytokine activity of patients with allergic rhinitis [Abstract]","volume":"95","author":"Alvarado","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0080","series-title":"Allergy Principles and Practice","first-page":"739","article-title":"Glucocorticosteroids: their mechanism of action and use in allergic diseases","author":"Schleimer","year":"1988"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4049\/jimmunol.137.1.150","article-title":"Effect of cyclosporin A and dexamethasone on interleukin-2 receptor gene expression","volume":"137","author":"Reed","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0090","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1172\/JCI115524","article-title":"Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell conditioned medium","volume":"88","author":"Her","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1398-9995.1997.tb04820.x","article-title":"The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids","volume":"52","author":"Meltzer","year":"1997","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jlb.37.2.193","article-title":"Reduction of serum interleukin-1-like activity after treatment with dexamethasone","volume":"37","author":"Staruch","year":"1985","journal-title":"J Leukoc Biol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4049\/jimmunol.155.1.410","article-title":"Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids","volume":"155","author":"Stellato","year":"1995","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00185082","article-title":"Antiinflammatory steroids inhibit GM-CSF production by human lung tissue","volume":"172","author":"Kato","year":"1994","journal-title":"Lung"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0115","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","article-title":"Glucocorticoids inhibit cytokine-mediated eosinophil survival","volume":"147","author":"Wallen","year":"1991","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/0091-6749(93)90317-9","article-title":"Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate","volume":"91","author":"van As","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0125","series-title":"The Mast Cell in Health and Disease","first-page":"483","article-title":"The effects of anti-inflammatory steroids on mast cells","author":"Schleimer","year":"1992"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0130","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/bmj.296.6636.1572-a","article-title":"Effect of topical corticosteroids on seasonally induced increases in nasal mast cells","volume":"296","author":"Gomez","year":"1988","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(88)90198-4","article-title":"Basophil influx occurs after nasal antigen challenge; effects of topical corticosteroid pretreatment","volume":"81","author":"Bascom","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0140","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198706113162403","article-title":"Inhibition of mediator release in allergic rhinitis by pretreatment with topical corticosteroids","volume":"316","author":"Pipkorn","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0145","first-page":"298","article-title":"Intranasal fluticasone propionate reduces histamine and tryptase in the mucosa of allergic rhinitis patients [Abstract]","volume":"91","author":"Meltzer","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm\/138.2.406","article-title":"The influx of inflammatory cells into nasal washings during the late response to antigen challenge","volume":"138","author":"Bascom","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0155","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.4049\/jimmunol.139.7.2303","article-title":"Interleukin-1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids","volume":"39","author":"Bochner","year":"1987","journal-title":"J Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0160","series-title":"Antiinflammatory Steroid Action: Basic and Clinical Aspects","first-page":"199","article-title":"Glucocorticoid action on monocytes and macrophages","author":"Guyre","year":"1991"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/278456a0","article-title":"Anti-inflammatory steroids induce biosyntesis of a phospholipase A2 inhibitor which prevents prostaglandin generation","volume":"278","author":"Flower","year":"1979","journal-title":"Nature"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1476-5381.1988.tb11614.x","article-title":"Lipocortin and the mechanism of action of the glucocorticoids","volume":"94","author":"Flower","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0175","first-page":"S39","article-title":"Effect of glucocorticosteroids on microvascular permeability","volume":"141","author":"Williams","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/ajrccm\/143.3.605","article-title":"Corticosteroid inhibition of microvascular leakage","volume":"143","author":"Boschetto","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0185","first-page":"L212","article-title":"Roles of neutral endopeptidase in airways","volume":"260","author":"Borson","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0190","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI114855","article-title":"Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea","volume":"86","author":"Piedimonte","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0195","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.02.02472001","article-title":"Mometasone furoate is a less specific glucocorticoid than fluticasone propionate","volume":"20","author":"Austin","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0200","first-page":"956","article-title":"In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids","volume":"48","author":"Smith","year":"1998","journal-title":"Arzneimittelforschung"},{"issue":"3 Suppl","key":"10.1097\/WOX.0b013e3181af7c93_bib0205","doi-asserted-by":"crossref","first-page":"139S","DOI":"10.1378\/chest.107.3_Supplement.139S","article-title":"Anti-inflammation: direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor","volume":"107","author":"Ray","year":"1995","journal-title":"Chest"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0210","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/j.1460-2075.1992.tb05283.x","article-title":"Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo","volume":"11","author":"Konig","year":"1992","journal-title":"EMBO J"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0215","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0039-128X(94)90054-X","article-title":"Binding kinetics of fluticasone propionate to the human glucocorticoid receptor","volume":"59","author":"H\u00f6gger","year":"1994","journal-title":"Steroids"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archderm.1962.01590110047006","article-title":"Percutaneous absorption of steroids","volume":"86","author":"McKenzie","year":"1962","journal-title":"Arch Dermatol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0225","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1016\/S0091-6749(98)70155-1","article-title":"Development of fluticasone propionate and comparison with other inhaled corticosteroids","volume":"101","author":"Johnson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1398-9995.1983.tb02354.x","article-title":"Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique","volume":"38","author":"Bende","year":"1983","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0235","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/S0091-6749(99)70310-6","article-title":"Intranasal corticosteroids for allergic rhinitis: how do different agents compare?","volume":"104","author":"Corren","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1258\/002221503322542818","article-title":"Intranasal steroid sprays in the treatment of rhinitis: is one better than another?","volume":"117","author":"Waddell","year":"2003","journal-title":"J Laryngol Otol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0091-6749(99)70334-9","article-title":"An in vitro comparison of commonly used topical glucocorticoid preparations","volume":"104","author":"Stellato","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0250","first-page":"199","article-title":"Treatment update: non-allergic rhinitis","volume":"22","author":"Lieberman","year":"2001","journal-title":"Allergy Asthma Proc"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1398-9995.1976.tb01683.x","article-title":"Treatment of vasomotor rhinitis with intranasal beclomethasone dipropionate","volume":"31","author":"Lofkvist","year":"1976","journal-title":"Acta Allergologica"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1398-9995.1976.tb01685.x","article-title":"Intranasal beclomethasone dipropionate in vasomotor rhinitis","volume":"31","author":"Malm","year":"1976","journal-title":"Acta Allergologica"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00405-002-0543-1","article-title":"Comparison of once versus twice daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis","volume":"260","author":"Giger","year":"2003","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1398-9995.1981.tb01836.x","article-title":"Reduction of metacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis","volume":"36","author":"Malm","year":"1981","journal-title":"Allergy"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/00016488309130931","article-title":"Long-term treatment with budesonide in vasomotor rhinitis","volume":"95","author":"Pipkorn","year":"1983","journal-title":"Acta Otolaryngol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1742-1241.1996.tb09577.x","article-title":"A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study","volume":"50","author":"Synnerstad","year":"1996","journal-title":"Br J Clin Pract"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0285","series-title":"Management of Allergic and Non Allergic Rhinitis","author":"Long","year":"2002"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00005537-199901000-00018","article-title":"Effects of steroids on nasal inflammatory cells and cytokine profile","volume":"109","author":"Kondo","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00016480510012219","article-title":"CT assessment of the effect of fluticasone propionate aqueous nasal spray on lower turbinate hypertrophy due to vasomotor rhinitis","volume":"126","author":"Arikan","year":"2006","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1081-1206(10)62369-1","article-title":"Intranasal fluticasone propionate is effective for perennial non-allergic rhinitis with or without eosinophilia","volume":"88","author":"Webb","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0305","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/000164801300366679","article-title":"Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a Nordic, multicenter, randomized, double-blind, placebo controlled study","volume":"121","author":"Lundblad","year":"2001","journal-title":"Acta Otolaryngol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0310","first-page":"77","article-title":"Treatment of non-allergic nasal hypersecretion with ipratropium and beclomethasone","volume":"328","author":"Jessen","year":"1990","journal-title":"Rhinology"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00130832-200102000-00004","article-title":"Non-allergic rhinitis; diagnosis and management","volume":"1","author":"Scadding","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181af7c93_bib0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1081-1206(10)63284-X","article-title":"Ipratropium bromide nasal spray 0.03% and beclomethasone spray alone and in combination for the treatment of rhinitis and perennial rhinitis","volume":"82","author":"Dockhorn","year":"1999","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119305435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119305435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:46:38Z","timestamp":1685079998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119305435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1939455119305435"],"URL":"https:\/\/doi.org\/10.1097\/wox.0b013e3181af7c93","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}